Eventide Asset Management, LLC Ascendis Pharma A/S Transaction History

Eventide Asset Management, LLC

$5.67 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $34 Million - $50.3 Million	-394,581 Reduced 68.57%	180,857 $22.8 Million
Q3 2023 Nov 14, 2023	BUY	$86.5 - $103.97 $519 - $623	6 Added 0.0%	575,438 $53.9 Million
Q2 2023 Aug 15, 2023	SELL	$69.96 - $97.84 $14.5 Million - $20.3 Million	-207,408 Reduced 26.49%	575,432 $51.4 Million
Q1 2023 May 15, 2023	BUY	$104.9 - $126.78 $13,741 - $16,608	131 Added 0.02%	782,840 $83.9 Million
Q4 2022 Feb 13, 2023	SELL	$99.42 - $131.97 $41.4 Million - $54.9 Million	-416,291 Reduced 34.72%	782,709 $95.6 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $10.2 Million - $15.3 Million	-130,432 Reduced 9.81%	1,199,000 $111 Million
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $42.8 Million - $56.9 Million	-419,216 Reduced 23.97%	1,329,432 $156 Million
Q3 2021 Nov 15, 2021	BUY	$112.67 - $176.92 $5.63 Million - $8.85 Million	50,000 Added 2.94%	1,748,648 $279 Million
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $687,060 - $953,315	-5,500 Reduced 0.32%	1,698,648 $219 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $861,839 - $1.04 Million	-5,700 Reduced 0.33%	1,704,148 $284 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $1.24 Million - $1.75 Million	11,200 Added 0.66%	1,709,848 $253 Million
Q4 2018 Feb 14, 2019	BUY	$55.16 - $69.67 $8.48 Million - $10.7 Million	153,748 Added 9.95%	1,698,648 $106 Million
Q3 2018 Nov 14, 2018	BUY	$63.77 - $76.28 $10.1 Million - $12 Million	157,900 Added 11.38%	1,544,900 $109 Million
Q2 2018 Aug 14, 2018	BUY	$58.55 - $73.92 $3.19 Million - $4.03 Million	54,460 Added 4.09%	1,387,000 $92.3 Million
Q4 2017 Feb 14, 2018	BUY	$31.98 - $40.38 $4.09 Million - $5.17 Million	128,000 Added 10.63%	1,332,540 $53.4 Million
Q3 2017 Nov 14, 2017	BUY	$26.89 - $37.1 $32.4 Million - $44.7 Million	1,204,540	1,204,540 $43.7 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Account